Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019)
Amneal Pharmaceuticals' (AMRX) quarterly Current Taxes came in at $8.7 million in Q4 2019, up 653.15% year-on-year from $1.2 million in Q4 2018, and up 653.15% quarter-over-quarter from $1.2 million in Q4 2018.
Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019) Analysis & Trends
Amneal Pharmaceuticals' Current Taxes history runs 2 years deep, the most recent figure standing at $8.7 million for Q4 2019.
- On a quarterly basis, Current Taxes rose 653.15% year-over-year to $8.7 million in Q4 2019; TTM through Dec 2019 was $8.7 million, a 653.15% increase from a year earlier, with the FY2019 full-year figure at $8.7 million, up 653.15% from the prior year.
- Current Taxes grew to $8.7 million in Q4 2019 per AMRX's latest filing, from $1.2 million in the prior quarter.
- Across five years, Current Taxes topped out at $8.7 million in Q4 2019 and bottomed at $1.2 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8.73 Mn |
| Dec 31, 2018 | 1.16 Mn |